Advanced Biology,
Journal Year:
2022,
Volume and Issue:
6(9)
Published: Aug. 11, 2022
Abstract
Brain
tumors
are
devastating
diseases
of
the
central
nervous
system.
tumor
pathogenesis
depends
on
both
tumor‐intrinsic
oncogenic
programs
and
extrinsic
microenvironmental
factors,
including
neurons
glial
cells.
Glial
cells
(oligodendrocytes,
astrocytes,
microglia)
make
up
half
in
brain,
interact
with
to
modulate
neurodevelopment
plasticity.
Many
brain
exhibit
transcriptomic
profiles
similar
macroglial
(oligodendrocytes
astrocytes)
their
progenitors,
making
them
likely
subvert
existing
neuron–glial
interactions
support
pathogenesis.
For
example,
oligodendrocyte
precursor
cells,
a
putative
glioma
cell
origin,
can
form
bona
fide
synapses
neurons.
Such
recently
identified
gliomas
drive
pathophysiology,
underscoring
how
take
advantage
cancer
progression.
In
this
review,
it
is
briefly
summarized
activity
normally
discussed
utilize
initiation
Unresolved
questions
these
topics
potential
avenues
therapeutically
target
neuron–glia–cancer
also
pointed
out.
Glia,
Journal Year:
2023,
Volume and Issue:
71(6), P. 1383 - 1401
Published: Feb. 17, 2023
Abstract
The
mammalian
brain
is
a
complex
organ
comprising
neurons,
glia,
and
more
than
1
×
10
14
synapses.
Neurons
are
heterogeneous
group
of
electrically
active
cells,
which
form
the
framework
circuitry
brain.
However,
glial
primarily
divided
into
astrocytes,
microglia,
oligodendrocytes
(OLs),
oligodendrocyte
precursor
cells
(OPCs),
constitute
approximately
half
all
neural
in
central
nervous
system
(CNS)
mainly
provide
nutrition
tropic
support
to
neurons
In
last
two
decades,
concept
“tripartite
synapses”
has
drawn
great
attention,
emphasizes
that
astrocytes
an
integral
part
synapse
regulate
neuronal
activity
feedback
manner
after
receiving
signals.
Since
then,
synaptic
modulation
by
been
extensively
studied
substantially
revised.
this
review,
we
summarize
latest
significant
findings
on
how
particular,
microglia
OL
lineage
impact
remodel
structure
function
synapses
Our
review
highlights
cellular
molecular
aspects
neuron‐glia
crosstalk
provides
additional
information
aberrant
communication
between
glia
may
contribute
pathologies.
Seminars in Immunology,
Journal Year:
2025,
Volume and Issue:
77, P. 101927 - 101927
Published: Jan. 6, 2025
The
complement
system
is
increasingly
recognised
as
a
key
player
in
tumour
progression
and
response
to
cancer
treatment.
Cytotoxic
therapies,
including
chemo-
radiotherapy
are
standard-of-care
for
the
majority
of
patients.
Cytotoxics
have
been
found
alter
expression
proteins
activation
components.
Many
recent
reports
highlight
role
local
dysregulation
microenvironment
how
targeting
such
can
either
anti-
or
pro-tumoricidal
effects
depending
on
several
factors
treatment
scheduling,
type
its
characteristics.
This
review
will
explore
complex
cytotoxic
therapy
regulation
what
lessons
be
learnt
identify
most
effective
way
therapeutically
modulate
therapy.
ImmunoTargets and Therapy,
Journal Year:
2021,
Volume and Issue:
Volume 10, P. 373 - 386
Published: Sept. 1, 2021
The
complement
system,
an
essential
part
of
the
innate
immune
is
composed
a
group
secreted
and
membrane
proteins
that
collectively
participate
in
maintaining
function
healthy
diseased
brain.
However,
inappropriate
activation
system
has
been
related
to
inflammatory
response
multiple
diseases,
such
as
stroke,
traumatic
brain
injury,
sclerosis,
Alzheimer's
disease,
well
Zika
infection
radiotherapy.
In
addition,
C1q
C3
(initial
components
cascade)
have
shown
play
key
beneficial
role
refinement
synaptic
circuits
during
developmental
stages
adult
plasticity.
Nevertheless,
excessive
pruning
can
be
detrimental
associated
with
loss
several
pathological
conditions.
this
brief
review,
we
will
discuss
its
contribution
neurodegeneration
cognitive
deficits.
We
also
mention
potential
therapeutic
approaches
target
treat
neuroinflammatory
diseases
unintended
consequences
Nature Medicine,
Journal Year:
2022,
Volume and Issue:
28(4), P. 752 - 765
Published: April 1, 2022
Abstract
Whole-brain
radiotherapy
(WBRT)
is
the
treatment
backbone
for
many
patients
with
brain
metastasis;
however,
its
efficacy
in
preventing
disease
progression
and
associated
toxicity
have
questioned
clinical
impact
of
this
approach
emphasized
need
alternative
treatments.
Given
limited
therapeutic
options
available
these
poor
understanding
molecular
mechanisms
underlying
resistance
metastatic
lesions
to
WBRT,
we
sought
uncover
actionable
targets
biomarkers
that
could
help
refine
patient
selection.
Through
an
unbiased
analysis
experimental
vivo
models
metastasis
resistant
identified
activation
S100A9–RAGE–NF-κB–JunB
pathway
metastases
as
a
potential
mediator
organ.
Targeting
genetically
or
pharmacologically
was
sufficient
revert
WBRT
increase
benefits
at
lower
doses
radiation.
In
primary
melanoma,
lung
breast
adenocarcinoma
developing
metastasis,
endogenous
S100A9
levels
correlated
response
underscored
blood
noninvasive
biomarker.
Collectively,
provide
framework
personalize
improve
through
combination
radiosensitizer
balances
benefit
toxicity.
Neurotherapeutics,
Journal Year:
2023,
Volume and Issue:
20(3), P. 838 - 852
Published: Jan. 31, 2023
Cancer-related
cognitive
impairment
(CRCI)
considerably
affects
the
quality
of
life
millions
cancer
survivors.
Brain-derived
neurotrophic
factor
(BDNF)
has
been
shown
to
promote
survival,
differentiation,
and
maintenance
in
vivo
dentate
neurogenesis,
chemotherapy
induces
a
plethora
physiological
cellular
alterations,
including
decline
neurogenesis
increased
neuroinflammation
linked
with
impairments.
In
our
clinical
studies,
breast
patients
treated
doxorubicin
(Adriamycin
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(15), P. 8286 - 8286
Published: July 27, 2022
Radiation-induced
brain
injury
(RIBI)
after
radiotherapy
has
become
an
increasingly
important
factor
affecting
the
prognosis
of
patients
with
head
and
neck
tumor.
With
delivery
high
doses
radiation
to
tissue,
microglia
rapidly
transit
a
pro-inflammatory
phenotype,
upregulate
phagocytic
machinery,
reduce
release
neurotrophic
factors.
Persistently
activated
mediate
progression
chronic
neuroinflammation,
which
may
inhibit
neurogenesis
leading
occurrence
neurocognitive
disorders
at
advanced
stage
RIBI.
Fully
understanding
microglial
pathophysiology
cellular
molecular
mechanisms
irradiation
facilitate
development
novel
therapy
by
targeting
prevent
RIBI
subsequent
neurological
neuropsychiatric
disorders.
Frontiers in Immunology,
Journal Year:
2022,
Volume and Issue:
13
Published: Aug. 10, 2022
The
complement
system
has
been
involved
in
the
pathogenesis
of
multiple
neuroinflammatory
and
neurodegenerative
conditions.
In
this
review,
we
evaluated
possible
role
activation
sclerosis
(MS)
with
a
focus
progressive
MS,
where
disease
remains
to
be
fully
elucidated
treatment
options
are
limited.
evidence
for
involvement
white
matter
plaques
gray
lesions
MS
stems
from
immunohistochemical
analysis
post-mortem
brains,
vivo
serum
cerebrospinal
fluid
biomarker
studies,
animal
models
Experimental
Autoimmune
Encephalomyelitis
(EAE).
Complement
knock-out
studies
these
have
revealed
that
may
“double-edge
sword”
effect
MS.
On
one
hand,
proteins
aid
promoting
clearance
myelin
degradation
products
other
debris
through
myeloid
cell-mediated
phagocytosis.
other,
its
aberrant
lead
demyelination
at
rim
as
well
synapse
loss
matter.
also
interact
known
risk
factors
including
Epstein
Barr
Virus
(EBV)
infection,
perpetuate
CNS
self-reactive
B
cell
populations.
With
mounting
development
modulating
therapies
condition
is
appealing.
Herein,
reviewed
pharmacological
inhibitors
tested
clinical
trials
neurologic
diseases.
potential
use
agents,
such
C5-binding
antibody
eculizumab
will
require
detailed
understanding
different
effectors
better
delivery
strategies
compounds.
Cancer Research Communications,
Journal Year:
2023,
Volume and Issue:
3(4), P. 725 - 737
Published: March 31, 2023
Implementation
of
ultra-high
dose-rate
FLASH
radiotherapy
(FLASH-RT)
is
rapidly
gaining
traction
as
a
unique
cancer
treatment
modality
able
to
dramatically
minimize
normal
tissue
toxicity
while
maintaining
antitumor
efficacy
compared
with
standard-of-care
at
conventional
dose
rate
(CONV-RT).
The
resultant
improvements
in
the
therapeutic
index
have
sparked
intense
investigations
pursuit
underlying
mechanisms.
As
preamble
clinical
translation,
we
exposed
non–tumor-bearing
male
and
female
mice
hypofractionated
(3
×
10
Gy)
whole
brain
FLASH-
CONV-RT
evaluate
differential
neurologic
responses
using
comprehensive
panel
functional
molecular
outcomes
over
6-month
follow-up.
In
each
instance,
extensive
rigorous
behavioral
testing
showed
FLASH-RT
preserve
cognitive
indices
learning
memory
that
corresponded
similar
protection
synaptic
plasticity
measured
by
long-term
potentiation
(LTP).
These
beneficial
were
not
found
after
linked
preservation
integrity
(synaptophysin)
level
reductions
neuroinflammation
(CD68+
microglia)
throughout
specific
regions
known
be
engaged
our
selected
tasks
(hippocampus,
medial
prefrontal
cortex).
Ultrastructural
changes
presynaptic/postsynaptic
bouton
(Bassoon/Homer-1
puncta)
within
these
same
differ
response
rate.
With
this
clinically
relevant
dosing
regimen,
provide
mechanistic
blueprint
from
synapse
cognition
detailing
how
reduces
complications
irradiated
brain.
Significance:
Functional
LTP
are
reduction
protracted
irradiation
times.
Oxidative Medicine and Cellular Longevity,
Journal Year:
2021,
Volume and Issue:
2021(1)
Published: Jan. 1, 2021
Radiation-induced
brain
necrosis
(RBN)
is
a
serious
complication
of
intracranial
as
well
skull
base
tumors
after
radiotherapy.
In
the
past,
due
to
lack
effective
treatment,
radiation
was
considered
be
progressive
and
irreversible.
With
better
understanding
in
histopathology
neuroimaging,
occurrence
development
RBN
have
been
gradually
clarified,
new
treatment
methods
are
constantly
emerging.
recent
years,
some
scholars
tried
treat
with
bevacizumab,
nerve
growth
factor,
gangliosides
achieved
similar
results.
Some
cases
can
repairable
reversible.
We
aimed
summarize
incidence,
pathogenesis,
RBN.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: April 3, 2024
Abstract
Cranial
irradiation
causes
cognitive
deficits
that
are
in
part
mediated
by
microglia,
the
resident
immune
cells
of
brain.
Microglia
highly
reactive,
exhibiting
changes
shape
and
morphology
depending
on
function
they
performing.
Additionally,
microglia
processes
make
dynamic,
physical
contacts
with
different
components
their
environment
to
monitor
functional
state
brain
promote
plasticity.
Though
evidence
suggests
radiation
perturbs
homeostatic
functions,
it
is
unknown
how
cranial
impacts
dynamic
behavior
over
time.
Here,
we
paired
vivo
two-photon
microscopy
a
transgenic
mouse
model
labels
cortical
follow
these
determine
change
time
irradiated
mice
control
littermates.
We
show
single
dose
10
Gy
disrupts
dynamics
during
1-month
course.
found
lasting
loss
microglial
following
irradiation,
coupled
modest
dysregulation
soma
displacement
at
earlier
timepoints.
The
homogeneous
distribution
was
maintained,
suggesting
rearrange
themselves
account
for
cell
maintain
territorial
organization
irradiation.
Furthermore,
reduced
coverage
parenchyma
surveillance
capacity,
without
overtly
changing
morphology.
Our
results
demonstrate
can
induce
could
influence
neurological
health.
These
set
foundation
future
work
examining
complex
cellular
which
contribute
manifestation
deficits.